Liu Peng, Wang Hanzhe, Wang Shijie, Shan Yazheng, Dong Nianguo, Wang Yin
Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Ave, Wuhan 430022, China.
J Clin Med. 2025 May 19;14(10):3542. doi: 10.3390/jcm14103542.
Aortic stenosis (AS) poses significant risks to patient survival and quality of life. The management of AS extends beyond restoring valve function to encompass lifelong disease management. While curative treatments exist, advancements in therapeutic approaches and prosthetic valve technology continue to evolve. This review synthesizes recent developments in AS treatment modalities, prosthetic valve innovations, and their clinical implications, delineating the current therapeutic landscape.
主动脉瓣狭窄（AS）对患者的生存和生活质量构成重大风险。AS的管理不仅限于恢复瓣膜功能，还包括终身疾病管理。虽然存在治愈性治疗方法，但治疗手段和人工瓣膜技术仍在不断发展。本综述综合了AS治疗方式、人工瓣膜创新及其临床意义的最新进展，描绘了当前的治疗前景。
